Differential replicative ability of clinical dengue virus isolates in an immunocompetent C57BL/6 mouse model.

Publisher: BioMed Central Country of Publication: England NLM ID: 100966981 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2180 (Electronic) Linking ISSN: 14712180 NLM ISO Abbreviation: BMC Microbiol Subsets: MEDLINE

Original Publication: London : BioMed Central, [2001-

Virus Replication*; Dengue/*virology ; Dengue Virus/*physiology; Animal Structures/virology ; Animals ; Antibodies, Blocking/metabolism ; Dengue Virus/isolation & purification ; Disease Models, Animal ; Humans ; Injections, Intraperitoneal ; Macrophages/virology ; Mice, Inbred C57BL ; Viral Tropism

Background: Several experimental animal models have been used to study the pathogenesis of dengue disease; however, most of the studies used laboratory-adapted viruses, which lack the virulence of viruses circulating in humans. The aim of this study was to analyze the ability of clinical Dengue virus (DENV) isolates (D2/BR/RP/RMB/09 and D3/BR/SL3/02) to infect immunocompetent C57BL/6 mice.
Methods: Two strategies of intraperitoneal infection, which were based on the concept of the antibody dependent enhancement phenomenon, were used. In one strategy, the animals were inoculated with macrophages infected in vitro with dengue viruses, which were incubated with enhancing antibodies, and in the other strategy, the animals were inoculated with a complex of enhancing antibodies and dengue viruses.
Results: The D3/BR/SL3/08 isolate showed a higher ability of infection (virus RNA was more frequently detected in the serum and in several organs) in the experimental model compared to both the D2/BR/RP/RMB/2009 isolate and a laboratory adapted DENV-1 strain (Mochizuki strain), regardless of the infection strategy used. The main features of the D3/BR/SL3/08 isolate were its neuroinvasiveness and the induction of an extended period of viremia. Enhancing antibodies did not influence on the infection of animals when macrophages were used, but the level of viremia was increased when they were used as a complex with a D3/BR/SL3/02 isolate.
Discussion: We showed that DENV isolates could infect immunocompetent C57BL/6 mice, which have has been previously used to study some aspect of dengue disease when infected with laboratory adapted strains. DENV genome was detected in the same organs found in humans when autopsy and biopsy samples were analyzed, showing that C57BL/6 mice reproduce some aspects of the DENV tropism observed in humans. The main difference observed between the D3/BR/SL3/02 and D2/BR/RP/RMB/2009 clinical isolates was the neuroinvasive ability of the first one. Neuroinvasiveness has been described in some DENV infected cases and is common for other members of the Flavivirus genus.
Conclusions: These results suggest that C57BL/6 mice can be used as an experimental model to evaluate virulence differences among DENV clinical isolates.

Clin Neuropathol. 2009 Nov-Dec;28(6):422-9. (PMID: 19919816)
Virol J. 2010;7:22. (PMID: 20105295)
Lancet. 1987 Jan 24;1(8526):193-4. (PMID: 2880019)
PLoS Pathog. 2007 Sep 14;3(9):1262-70. (PMID: 17941708)
Bacteriol Rev. 1950 Sep;14(3):225-32. (PMID: 14772197)
Clin Neuropathol. 1997 Jul-Aug;16(4):204-8. (PMID: 9266146)
Drug Discov Today Dis Models. 2006;3(1):97-103. (PMID: 18087566)
Emerg Infect Dis. 2009 Feb;15(2):192-9. (PMID: 19193262)
Yale J Biol Med. 1970 Apr;42(5):350-62. (PMID: 5419208)
Res Exp Med (Berl). 1984;184(3):159-69. (PMID: 6473905)
J Infect Dis. 2002 Oct 15;186(8):1165-8. (PMID: 12355369)
Microbes Infect. 2010 Jul;12(7):546-54. (PMID: 20381635)
Eur J Immunol. 2013 Jun;43(6):1529-44. (PMID: 23505056)
PLoS One. 2014;9(11):e112351. (PMID: 25383618)
J Exp Med. 1992 Sep 1;176(3):707-12. (PMID: 1512538)
Vector Borne Zoonotic Dis. 2001 Summer;1(2):159-68. (PMID: 12680353)
Brain Res. 1989 Sep 4;496(1-2):314-6. (PMID: 2804640)
J Infect Dis. 2007 Jun 15;195(12):1808-17. (PMID: 17492597)
Emerg Infect Dis. 2003 Jul;9(7):800-9. (PMID: 12899133)
J Infect Dis. 2000 Jan;181(1):2-9. (PMID: 10608744)
J Immunol. 1954 Nov;73(5):363-73. (PMID: 13212058)
J Med Virol. 2008 Aug;80(8):1426-33. (PMID: 18551599)
Cell Tissue Res. 1998 Sep;293(3):389-94. (PMID: 9716728)
Toxicon. 2012 Mar 15;59(4):507-15. (PMID: 21723310)
Virol J. 2012;9:124. (PMID: 22716071)
Am J Trop Med Hyg. 2006 Oct;75(4):710-5. (PMID: 17038699)
Southeast Asian J Trop Med Public Health. 2002 Mar;33(1):68-71. (PMID: 12118463)
Curr Top Microbiol Immunol. 2010;338:45-55. (PMID: 19802577)
Arch Virol. 2013 Jul;158(7):1445-59. (PMID: 23471635)
Int J Exp Pathol. 1992 Oct;73(5):603-11. (PMID: 1329914)
Lancet. 2000 Mar 25;355(9209):1053-9. (PMID: 10744091)
J Gen Virol. 2007 Feb;88(Pt 2):365-75. (PMID: 17251552)
J Virol. 2008 Dec;82(24):12312-24. (PMID: 18842737)
PLoS One. 2010;5(12):e15680. (PMID: 21206747)
J Infect Dis. 2010 Mar 15;201(6):923-35. (PMID: 20158392)
Science. 1960 Apr 15;131(3407):1102-3. (PMID: 14399343)
Annu Rev Cell Dev Biol. 1996;12:697-715. (PMID: 8970741)
Cell Host Microbe. 2010 Feb 18;7(2):128-39. (PMID: 20153282)
Lancet. 1999 Oct 23;354(9188):1431-4. (PMID: 10543670)
ScientificWorldJournal. 2012;2012:525947. (PMID: 22666132)
J Infect Dis. 2004 Apr 15;189(8):1411-8. (PMID: 15073678)
Viruses. 2012 Jan;4(1):62-82. (PMID: 22355452)
Am J Trop Med Hyg. 2009 Mar;80(3):416-24. (PMID: 19270292)
J Virol. 2011 Jun;85(11):5374-83. (PMID: 21450836)
Asian Pac J Allergy Immunol. 1996 Dec;14(2):107-13. (PMID: 9177824)
J Virol. 2007 Jun;81(11):5518-26. (PMID: 17360740)
Cell Host Microbe. 2013 Apr 17;13(4):379-93. (PMID: 23601101)
J Virol. 2010 May;84(9):4845-50. (PMID: 20164230)
J Exp Med. 1977 Jul 1;146(1):201-17. (PMID: 406347)
Science. 2010 May 7;328(5979):745-8. (PMID: 20448183)
Southeast Asian J Trop Med Public Health. 2001 Jun;32(2):341-5. (PMID: 11556587)
Hum Pathol. 1999 Sep;30(9):1106-10. (PMID: 10492047)
J Virol. 2004 Mar;78(6):2701-10. (PMID: 14990690)
Neurol Int. 2012 Oct 5;4(3):e15. (PMID: 23355928)
Nat Rev Immunol. 2011 May;11(5):318-29. (PMID: 21508982)
J Neurovirol. 1998 Aug;4(4):465-8. (PMID: 9718141)

0 (Antibodies, Blocking)

Date Created: 20150930 Date Completed: 20160108 Latest Revision: 20181113

20221213

PMC4587874

10.1186/s12866-015-0520-7

26415508